0001104659-24-089794.txt : 20240814 0001104659-24-089794.hdr.sgml : 20240814 20240814192837 ACCESSION NUMBER: 0001104659-24-089794 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240814 FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYTLE PAUL J CENTRAL INDEX KEY: 0001244110 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42139 FILM NUMBER: 241210170 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACTUATE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001652935 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473044785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1751 RIVER RUN STREET 2: SUITE 400 CITY: FORT WORTH STATE: TX ZIP: 76107 BUSINESS PHONE: 847-986-4190 MAIL ADDRESS: STREET 1: 1751 RIVER RUN STREET 2: SUITE 400 CITY: FORT WORTH STATE: TX ZIP: 76107 FORMER COMPANY: FORMER CONFORMED NAME: Apotheca Therapeutics, Inc. DATE OF NAME CHANGE: 20150911 4 1 tm2421559-4_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-08-14 0 0001652935 ACTUATE THERAPEUTICS, INC. ACTU 0001244110 LYTLE PAUL J C/O ACTUATE THERAPEUTICS, INC. 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 0 1 0 0 Chief Financial Officer 0 Non-Qualified Stock Options 8.00 2024-08-14 4 A 0 234971 0 A 2034-08-14 Common Stock 234971 0 D 234,971 stock options granted upon the closing of the issuer's initial public offering on August 14, 2024, 25% of which vest on June 1, 2025 and the remaining 75% of which vest in equal monthly installments during the 36 months following June 1, 2025. /s/ Paul Lytle 2024-08-14